Authors:
WAGNER DR
COMBES A
MCTIERNAN C
SANDERS VJ
LEMSTER B
FELDMAN AM
Citation: Dr. Wagner et al., ADENOSINE INHIBITS LIPOPOLYSACCHARIDE-INDUCED CARDIAC EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA, Circulation research, 82(1), 1998, pp. 47-56
Authors:
WOO J
WRIGHT TM
LEMSTER B
BOROCHOVITZ D
NALESNIK MA
THOMSON AW
Citation: J. Woo et al., COMBINED EFFECTS OF FK506 (TACROLIMUS) AND CYCLOPHOSPHAMIDE ON ATYPICAL B220(-CELLS, CYTOKINE GENE-EXPRESSION AND DISEASE-ACTIVITY IN MRL()T)MPJ-LPR/LPR MICE/, Clinical and experimental immunology, 100(1), 1995, pp. 118-125
Authors:
WOO J
WRIGHT TM
LEMSTER B
FERTIG N
THOMSON AW
Citation: J. Woo et al., FK506 PLUS CYLOPHOSPHAMIDE MARKEDLY REDUCES ATYPICAL B220-CELLS AND HAS SYNERGISTIC THERAPEUTIC EFFICACY IN THE AUTOIMMUNE MRL(T)1PR MOUSE/, The FASEB journal, 8(5), 1994, pp. 10000979-10000979
Authors:
LEMSTER B
HUANG LL
IRISH W
WOO J
CARROLL PB
ABUELMAGD K
RILO HR
JOHNSON N
RUSSELLHALL R
FUNG JJ
STARZL TE
EIDELMAN B
THOMSON AW
Citation: B. Lemster et al., INFLUENCE OF FK-506 (TACROLIMUS) ON CIRCULATING CD4(-CELLS EXPRESSINGCD25 AND CD45RA ANTIGENS IN 19 PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS PARTICIPATING IN AN OPEN-LABEL DRUG SAFETY TRIAL() T), Autoimmunity, 19(2), 1994, pp. 89-98
Citation: B. Lemster et al., BLOOD-LYMPHOCYTES OF AUTOIMMUNE-DISEASE PATIENTS RECEIVING FK506 EXHIBIT NORMAL EX-VIVO CYTOKINE GENE-EXPRESSION AND PROLIFERATIVE RESPONSES, Immunology letters, 38(3), 1993, pp. 179-183
Authors:
WOO J
LEMSTER B
TAMURA K
STARZL TE
THOMSON AW
Citation: J. Woo et al., THE ANTILYMPHOCYTIC ACTIVITY OF BREQUINAR SODIUM AND ITS POTENTIATIONBY CYTIDINE - EFFECTS ON LYMPHOCYTE-PROLIFERATION AND CYTOKINE PRODUCTION, Transplantation, 56(2), 1993, pp. 374-381
Authors:
LEMSTER B
WOO J
IRISH W
CARROLL PB
RILO HR
ABUELMAGD K
EIDELMAN B
THOMSON AW
Citation: B. Lemster et al., INVERSE CORRELATION BETWEEN IL-2R-ALPHA-CELLS IN PROGRESSIVE MULTIPLE-SCLEROSIS AND THE INFLUENCE OF SHORT-TERM (3 MONTHS) FK-506 THERAPY( AND 2H4+ T), The Journal of immunology, 150(8), 1993, pp. 73-73